Ganciclovir 500mg InjectionInjection
Antiviral

Ganciclovir 500mg Injection

Ganciclovir Sodium

Nucleoside analog active against CMV for treatment of CMV retinitis and prophylaxis in transplant recipients. Manufactured by Cipla for hospital infectious disease export.

Strengths

500mg

Packing

1 vial/box

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Ganciclovir Sodium equivalent to Ganciclovir 500mg lyophilized powder for IV infusion
Dosage Form
Injection
Available Strengths
500mg
Packing
1 vial/box
Route of Administration
Intravenous infusion over 1 hour
Dosage
Induction: 5mg/kg IV every 12 hours for 14-21 days; Maintenance: 5mg/kg IV once daily 7 days/week or 6mg/kg 5 days/week
Indications
CMV retinitis in immunocompromised patients, CMV prophylaxis in solid organ and bone marrow transplant recipients
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
36 months
Side Effects
Neutropenia, thrombocytopenia, anemia, fever, rash, diarrhea, nausea, renal impairment
Precautions
Myelosuppression — monitor CBC twice weekly during induction; dose adjust for renal impairment; teratogenic — contraception required; carcinogenic potential; hydrate adequately

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Ganciclovir 500mg Injection?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote